Scholars@Duke

"Me-too" products--friend or foe?

Publication ,  Journal Article
Frothingham, R
Published in: N Engl J Med
May 13, 2004
Published version (DOI) Link to item

Duke Scholars

Richard Frothingham
Author Richard Frothingham Medicine, Infectious Diseases

Published In

N Engl J Med

DOI

10.1056/NEJM200405133502019

EISSN

1533-4406

Publication Date

May 13, 2004

Volume

350

Issue

20

Start / End Page

2100 / 2101

Location

United States

Related Subject Headings

  • Quinolines
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Gatifloxacin
  • Fluoroquinolones
  • Drug Costs
  • Cost-Benefit Analysis
  • Cost Savings
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Frothingham, R. (2004). "Me-too" products--friend or foe? N Engl J Med, 350(20), 2100–2101. https://doi.org/10.1056/NEJM200405133502019
Frothingham, Richard. “"Me-too" products--friend or foe?” N Engl J Med 350, no. 20 (May 13, 2004): 2100–2101. https://doi.org/10.1056/NEJM200405133502019.
Frothingham R. "Me-too" products--friend or foe? N Engl J Med. 2004 May 13;350(20):2100–1.
Frothingham, Richard. “"Me-too" products--friend or foe?” N Engl J Med, vol. 350, no. 20, May 2004, pp. 2100–01. Pubmed, doi:10.1056/NEJM200405133502019.
Frothingham R. "Me-too" products--friend or foe? N Engl J Med. 2004 May 13;350(20):2100–2101.

Published In

N Engl J Med

DOI

10.1056/NEJM200405133502019

EISSN

1533-4406

Publication Date

May 13, 2004

Volume

350

Issue

20

Start / End Page

2100 / 2101

Location

United States

Related Subject Headings

  • Quinolines
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Gatifloxacin
  • Fluoroquinolones
  • Drug Costs
  • Cost-Benefit Analysis
  • Cost Savings
  • 42 Health sciences